Log in
Enquire now
‌

US Patent 10701081 Automated authorization response techniques

Patent 10701081 was granted and assigned to Salesforce.com, Inc. on June, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Current Assignee
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10701081
Date of Patent
June 30, 2020
Patent Application Number
16290678
Date Filed
March 1, 2019
Patent Citations Received
‌
US Patent 11853691 Automated clinical documentation system and method
0
‌
US Patent 12008310 Automated clinical documentation system and method
0
‌
US Patent 11930014 Information security using multi-factor authorization
0
‌
US Patent 12073361 Automated clinical documentation system and method
0
‌
US Patent 12062016 Automated clinical documentation system and method
0
‌
US Patent 11593807 Information security system and method for multi-factor authentication for ATMS using authentication media
‌
US Patent 11750639 ATM-based anomaly and security threat detection
‌
US Patent 11777947 Ambient cooperative intelligence system and method
Patent Primary Examiner
‌
Joseph P Hirl
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10701081 Automated authorization response techniques

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.